These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23892628)

  • 1. GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.
    Coma S; Allard-Ratick M; Akino T; van Meeteren LA; Mammoto A; Klagsbrun M
    Angiogenesis; 2013 Oct; 16(4):939-52. PubMed ID: 23892628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.
    Coma S; Shimizu A; Klagsbrun M
    Cell Adh Migr; 2011; 5(3):266-75. PubMed ID: 21610314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration.
    Matrone G; Meng S; Gu Q; Lv J; Fang L; Chen K; Cooke JP
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1860-1868. PubMed ID: 28775072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program.
    Frye M; Taddei A; Dierkes C; Martinez-Corral I; Fielden M; Ortsäter H; Kazenwadel J; Calado DP; Ostergaard P; Salminen M; He L; Harvey NL; Kiefer F; Mäkinen T
    Nat Commun; 2018 Apr; 9(1):1511. PubMed ID: 29666442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDB2 regulates the expression of DLL4 through the formation of oligomeric complexes in endothelial cells.
    Choi HJ; Rho SS; Choi DH; Kwon YG
    BMB Rep; 2018 Jan; 51(1):21-26. PubMed ID: 28946938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression.
    Geretti E; van Meeteren LA; Shimizu A; Dudley AC; Claesson-Welsh L; Klagsbrun M
    Mol Cancer Res; 2010 Aug; 8(8):1063-73. PubMed ID: 20651020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration.
    Meng S; Matrone G; Lv J; Chen K; Wong WT; Cooke JP
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development.
    Lin FJ; Chen X; Qin J; Hong YK; Tsai MJ; Tsai SY
    J Clin Invest; 2010 May; 120(5):1694-707. PubMed ID: 20364082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.
    Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P
    Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
    Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
    J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis.
    Yamada Y; Zhong Y; Miki S; Taura A; Rabbitts TH
    Sci Rep; 2022 May; 12(1):7226. PubMed ID: 35508511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
    Ou JJ; Wei X; Peng Y; Zha L; Zhou RB; Shi H; Zhou Q; Liang HJ
    Cancer Lett; 2015 Mar; 358(2):200-209. PubMed ID: 25543087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2.
    Chan YC; Roy S; Khanna S; Sen CK
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1372-82. PubMed ID: 22499991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
    Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
    Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.
    Bonadies N; Göttgens B; Calero-Nieto FJ
    PLoS One; 2015; 10(7):e0131577. PubMed ID: 26161748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The β
    Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity.
    Sulpice E; Plouët J; Bergé M; Allanic D; Tobelem G; Merkulova-Rainon T
    Blood; 2008 Feb; 111(4):2036-45. PubMed ID: 18065694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.